Published in Mol Pharmacol on December 01, 1991
Quantification of signalling components and amplification in the beta-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes. Biochem J (1995) 1.25
Reduced beta adrenoceptor density in vivo in human lung tumours: a preliminary study with positron emission tomography. Thorax (1996) 0.75
Mouse thymic iso-antigens. Nature (1966) 6.01
Introns increase transcriptional efficiency in transgenic mice. Proc Natl Acad Sci U S A (1988) 5.18
Warming experiments underpredict plant phenological responses to climate change. Nature (2012) 3.64
Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol (2000) 3.13
Concerned about unlicensed practice. J Am Vet Med Assoc (1991) 3.11
A model of the kinetics of insulin in man. J Clin Invest (1974) 2.97
Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J Virol (2001) 2.95
Glycosylation and antigenic variation among Kunjin virus isolates. Virology (1995) 2.40
Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A (2000) 2.35
Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol (2000) 2.26
Cardiac tamponade in medical patients. Circulation (1981) 2.11
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood (1977) 2.10
Insulin control of glucose metabolism in man: a new kinetic analysis. J Clin Invest (1975) 2.09
Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J Biol Chem (2001) 2.08
Are there multiple imidazoline binding sites? Trends Pharmacol Sci (1989) 2.07
Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus-specific antibodies in sentinel animal serum. J Virol Methods (1995) 2.06
RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking. Science (2001) 2.05
The Physicians' Desk Reference. Problems and possible improvements. Arch Intern Med (1996) 2.03
Unlicensed practice. J Am Vet Med Assoc (1993) 2.02
Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol (1999) 1.98
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist. Br Med J (Clin Res Ed) (1983) 1.93
Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations. N Engl J Med (1982) 1.87
Developmental regulation of lck gene expression in T lymphocytes. J Exp Med (1991) 1.82
Management of nonspecific low back pain by physiotherapists in Britain and Ireland. A descriptive questionnaire of current clinical practice. Spine (Phila Pa 1976) (1999) 1.82
Home Use of an Artificial Beta Cell in Type 1 Diabetes. N Engl J Med (2015) 1.75
Cadiovascular complications of homozygous familial hypercholesterolaemia. Br Heart J (1980) 1.69
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Lack of effect of transcutaneous electrical nerve stimulation upon experimentally induced delayed onset muscle soreness in humans. Pain (1996) 1.65
Calcitonin gene-related peptide in cardiovascular tissues of the rat. Neuroscience (1985) 1.55
Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. N Engl J Med (1978) 1.51
Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth. Science (1975) 1.51
Stimulation of forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase. J Biol Chem (1982) 1.49
The UBX domain: a widespread ubiquitin-like module. J Mol Biol (2001) 1.49
Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior. Science (1994) 1.46
Stimulation of beta-adrenergic receptors of S49 lymphoma cells redistributes the alpha subunit of the stimulatory G protein between cytosol and membranes. Proc Natl Acad Sci U S A (1989) 1.46
Differential distribution of alpha subunits and beta gamma subunits of heterotrimeric G proteins on Golgi membranes of the exocrine pancreas. J Cell Biol (1996) 1.43
G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. Handb Exp Pharmacol (2008) 1.41
Agonist-specific refractoriness induced by isoproterenol. Studies with mutant cells. J Biol Chem (1976) 1.39
Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways. J Biol Chem (2000) 1.39
A structural gene mutation affecting the regulatory subunit of cyclic AMP-dependent protein kinase in mouse lymphoma cells. Proc Natl Acad Sci U S A (1975) 1.36
The enzymatic characteristics of peroxisomes of amphibian and avian liver and kidney. Ann N Y Acad Sci (1969) 1.35
A DNA segment controlling metal-regulated expression of the Drosophila melanogaster metallothionein gene Mtn. Mol Cell Biol (1987) 1.34
FcgammaRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. J Biol Chem (1998) 1.32
Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors. Circ Res (1983) 1.32
Neuropeptide tyrosine (NPY)--a major cardiac neuropeptide. Lancet (1983) 1.31
Two distinct regions of FC gamma RI initiate separate signalling pathways involved in endocytosis and phagocytosis. EMBO J (1995) 1.30
Stoichiometry of receptor-Gs-adenylate cyclase interactions. FASEB J (1991) 1.30
Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart. Regul Pept (1983) 1.29
Human papillomavirus in the oral cavities of children and adolescents. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2001) 1.29
Action of concanavalin A on the attachment stage of phagocytosis by macrophages. Exp Cell Res (1971) 1.28
Biochemical methods for detection and measurement of cyclic AMP and adenylyl cyclase activity. Methods Mol Biol (2000) 1.27
Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine. Biochem Biophys Res Commun (1980) 1.25
Quantification of signalling components and amplification in the beta-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes. Biochem J (1995) 1.25
Inhibition of polymorphonuclear leukocyte adherence by prostacyclin. J Lab Clin Med (1980) 1.24
Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving G(s). J Pharmacol Exp Ther (2000) 1.23
Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Mol Pharmacol (2000) 1.23
[3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site. Mol Pharmacol (1989) 1.22
Regulation of adenylate cyclase of human platelet membranes by forskolin. J Biol Chem (1982) 1.22
In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans. Pharmacogenetics (2001) 1.21
Nitric oxide mediates sexual behavior in female rats. Proc Natl Acad Sci U S A (1994) 1.20
Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood (1982) 1.20
Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor. Endocrinology (1994) 1.18
Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology (1985) 1.18
Radioimmunoassay of neuropeptide Y. Regul Pept (1984) 1.18
Quantitation of the guanine nucleotide binding regulatory protein Gs in S49 cell membranes using antipeptide antibodies to alpha s. J Biol Chem (1988) 1.17
Reduced beta-adrenergic receptor activation decreases G-protein expression and beta-adrenergic receptor kinase activity in porcine heart. J Clin Invest (1995) 1.17
Stress concentrations at the apex of pinned, implanted teeth. J Dent Res (1976) 1.17
Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A (1998) 1.17
Alpha 1-adrenergic receptors promote phosphatidylcholine hydrolysis in MDCK-D1 cells. A mechanism for rapid activation of protein kinase C. J Biol Chem (1988) 1.16
Seasonal distribution of pathogenic free-living amebae in Oklahoma waters. Parasitol Res (1995) 1.15
Alpha 1-adrenergic receptor-mediated phosphoinositide hydrolysis and prostaglandin E2 formation in Madin-Darby canine kidney cells. Possible parallel activation of phospholipase C and phospholipase A2. J Biol Chem (1987) 1.15
Diminished polymorphonuclear leukocyte adherence. Function dependent on release of cyclic AMP by endothelial cells after stimulation of beta-receptors by epinephrine. J Clin Invest (1980) 1.13
Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion (1984) 1.13
Peripheral adrenergic receptors in hypertension. Hypertension (1990) 1.13
Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep (2000) 1.12
Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. Mol Endocrinol (1996) 1.12
Time-dependent decreases in binding affinity of agonists for beta-adrenergic receptors of intact S49 lymphoma cells. A mechanism of desensitization. J Biol Chem (1983) 1.12
Binding of monomeric immunoglobulin G triggers Fc gamma RI-mediated endocytosis. J Biol Chem (1994) 1.12
Mouse nervous tissue iso-antigens. Nature (1966) 1.11
Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens. Neuropeptides (1982) 1.11
Neutropenia induced by systemic infusion of lactoferrin. J Lab Clin Med (1982) 1.11
Effect of norepinephrine on contractility of isolated mesenteric lymphatics. Am J Physiol (1983) 1.11
Verapamil competitively inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium. J Cardiovasc Pharmacol (1982) 1.09
Genetic analysis of beta-adrenergic receptor internalization and down-regulation. Proc Natl Acad Sci U S A (1985) 1.09
Metabolism of alpha- and beta-adrenergic receptors in vitro and in vivo. Annu Rev Pharmacol Toxicol (1987) 1.09
Subunit dissociation is the mechanism for hormonal activation of the Gs protein in native membranes. J Biol Chem (1988) 1.09
Genetic variations and polymorphisms of G protein-coupled receptors: functional and therapeutic implications. Annu Rev Pharmacol Toxicol (2001) 1.08
Influence of sodium on the alpha 2-adrenergic receptor system of human platelets. Role for intraplatelet sodium in receptor binding. J Biol Chem (1983) 1.08
ICMSF methods studies. XIII. An international comparative study of the MPN procedure and the Anderson-Baird-Parker direct plating method for the enumeration of Escherichia coli biotype I in raw meats. Can J Microbiol (1979) 1.08
Beta adrenergic receptors of polymorphonuclear particulates in bronchial asthma. J Clin Invest (1980) 1.08
BiaCore analysis of leptin-leptin receptor interaction: evidence for 1:1 stoichiometry. Anal Biochem (2004) 1.07
Neuropeptide tyrosine (NPY) immunoreactivity in norepinephrine-containing cells and nerves of the mammalian adrenal gland. Endocrinology (1984) 1.06
A study of the attachment phase of phagocytosis by murine macrophages. Exp Cell Res (1970) 1.06
High concentrations of a novel peptide, neuropeptide Y, in the innervation of mouse and rat heart. J Histochem Cytochem (1984) 1.06
Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J Clin Invest (1990) 1.06